Engene Therapeutics Inc (ENGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
(Values in U.S. thousands)
| 01-2026 | 10-2025 | 07-2025 | 04-2025 | 01-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 36,613 | 50,152 | 32,623 | 57,545 | 62,346 |
| Marketable Securities | 239,409 | 143,663 | 169,362 | 159,919 | 151,542 |
| Receivables | 1,197 | 927 | 709 | 533 | 430 |
| TOTAL | $289,216 | $201,391 | $211,312 | $227,974 | $222,320 |
| Non-Current Assets | |||||
| PPE Net | 2,441 | 2,477 | 1,879 | 1,553 | 1,366 |
| Investments And Advances | 36,601 | 8,522 | 23,011 | 34,109 | 58,979 |
| Other Non-Current Assets | 8,855 | 9,078 | 9,348 | 3,015 | 3,267 |
| TOTAL | $47,897 | $20,077 | $34,238 | $38,677 | $63,612 |
| Total Assets | $337,113 | $221,468 | $245,550 | $266,651 | $285,932 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,435 | 6,688 | 2,384 | 1,567 | 2,605 |
| Accrued Expenses | 19,668 | 15,275 | 11,117 | 12,433 | 8,244 |
| TOTAL | $24,609 | $31,979 | $20,440 | $18,001 | $12,955 |
| Non-Current Liabilities | |||||
| Long Term Debt | 24,736 | 15,324 | 17,706 | 20,023 | 21,696 |
| Other Non-Current Liabilities | 6,222 | 6,455 | 6,732 | 1,336 | 1,331 |
| TOTAL | $30,958 | $21,779 | $24,438 | $21,359 | $23,027 |
| Total Liabilities | $55,567 | $53,758 | $44,878 | $39,360 | $35,982 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 66,989 | 66,985 | 51,192 | 51,105 | 50,978 |
| Common Shares | 631,992 | 513,281 | 510,164 | 510,121 | 509,812 |
| Retained earnings | -401,784 | -372,032 | -334,152 | -305,161 | -279,346 |
| Other shareholders' equity | -842 | -888 | -1,209 | -969 | -1,275 |
| TOTAL | $281,546 | $167,710 | $200,672 | $227,291 | $249,950 |
| Total Liabilities And Equity | $337,113 | $221,468 | $245,550 | $266,651 | $285,932 |